GleamWall
中文EN

HAO Haoxi Health Technology Ltd Annual reports only

Services-Advertising Agencies · Nasdaq · SEC CIK 1954594 · Fiscal year ends 06/30

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY67.1%
TTM net income YoY-346.0%
TTM EPS YoY-111.4%
Revenue 3-yr CAGR24.8%
Net income 3-yr CAGR—

Margins

Gross margin1.1%
Operating margin-17.6%
Net margin-17.4%
FCF margin—
EBITDA margin-17.1%

Returns

ROE-54.1%
ROA-44.2%
ROIC (approx.)-93.7%
Asset turnover2.54x

Leverage & solvency

Liabilities / assets17.2%
Debt / equity0.00x
Current ratio4.53x
Interest coverage-184.27x

Cash quality & payout

Operating cash flow / net income0.27x
Accruals ratio-32.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-06-30FY20252025-06-30
Income statement
Revenue$54.83M$32.80M
Cost of revenue$54.20M$31.88M
Gross profit$629,090$927,750
R&D expense$104,357$79,544
SG&A expense$8.61M$2.80M
Operating income-$9.66M-$2.00M
Interest expense$52,446$45,956
Pretax income-$9.50M$4.15M
Income tax$36,614$270,744
Net income-$9.54M$3.88M
EBITDA-$9.36M-$1.71M
EPS (basic)-386.404,251.81
EPS (diluted)-386.403,385.53
Weighted avg. shares (diluted)24,680936
Balance sheet
Cash & equivalents$10.93M$8.62M
Receivables$5,944$460,272
Current assets$16.81M$19.60M
PP&E, net$104,169$108,899
Intangibles—$1.80M
Total assets$21.57M$21.60M
Current liabilities$3.71M$3.91M
Short-term debt$290,710$300,338
Long-term debt—$307,323
Total debt—$607,661
Total liabilities$3.71M$4.22M
Shareholders' equity$17.86M$17.38M
Net debt—-$8.01M
Cash flow statement
Operating cash flow-$2.57M-$3.36M
Investing cash flow-$4.50M-$3.58M
Financing cash flow$9.33M$8.90M
Depreciation & amortization$308,615$294,611
Stock-based compensation—$58,602

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.